Rebus Biosystems Launches Automated Spatial Omics Platform
The spatial omics platform will allow researchers to better understand the biology of tissues using patented Synthetic Aperture Optics technology.
Read MorePosted by Melanie Hamilton-Basich | Mar 2, 2021 | Anatomic Pathology |
The spatial omics platform will allow researchers to better understand the biology of tissues using patented Synthetic Aperture Optics technology.
Read MorePosted by Laurie Bonner | Feb 25, 2021 | Company News, Covid 19, POC Rapid Assays |
These funds will enable the company to develop a point-of-care antigen test that delivers results in less than 6 minutes.
Read MorePosted by Laurie Bonner | Feb 23, 2021 | Company News, Molecular Diagnostics |
Thermo Fisher Scientific is now calling for proposals dedicated to liquid biopsy research. Each proposal may receive an award worth up to $200,000 in reagents and funding.
Read MorePosted by Melanie Hamilton-Basich | Feb 22, 2021 | Covid 19 |
The test uses AnteoTech’s AnteoBind technology to support significantly improved sensitivity, and is the first covid-19 rapid self-test authorized by the FDA.
Read MorePosted by Laurie Bonner | Feb 22, 2021 | Compliance, Covid 19 |
The new guidances for medical product developers, specifically covering vaccines, diagnostics, and therapeutic products, address the emergence and potential future emergence of variants of SARS-CoV-2, the virus that causes covid-19.
Read More